Back to search
FDAFDA · Food and drugs·Recall number D-1502-2014

Benicar Tablets (olmesartan medoxomil) 20 mg, 30 and 90 count, Rx Only Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 --- NDC 65597-103-30 and NDC 65597-103-90

Published August 6, 2014 · Recall initiated: July 12, 2014

Summary

FDA records drug Class II recall D-1502-2014, published August 6, 2014 and initiated July 12, 2014. Recalling firm: Daiichi Sankyo Pharma Development; Status: Terminated; Reported quantity: 262 bottles; Lot: 30 count - Lot #0002055 Exp - 11/30/2016; 90 count - Lot #0002063 Exp - 12/31/2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Daiichi Sankyo Pharma Development
Distributor
Nationwide
Lot
30 count - Lot #0002055 Exp - 11/30/2016; 90 count - Lot #0002063 Exp - 12/31/2016
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Benicar Tablets (olmesartan medoxomil) 20 mg, 30 and 90 count, Rx Only Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 --- NDC 65597-103-30 and NDC 65597-103-90 recalled?

Yes. FDA published recall D-1502-2014 on August 6, 2014. Reported hazard: Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping

What should I do if I have this product?

Voluntary: Firm initiated · Telephone